Keyphrases
Ocular Toxoplasmosis
100%
Implications for Treatment
100%
Immunopathogenesis
100%
Ocular Involvement
66%
Polymorphism
33%
Genetic Polymorphism
33%
Immunological Characteristics
33%
South America
33%
Protozoa
33%
Clinical Management
33%
Interferon-γ
33%
Toxoplasma Gondii (T. gondii)
33%
Aqueous Humor
33%
Clinical Manifestations
33%
Immune Response
33%
Primary Infection
33%
Peripheral Blood Mononuclear Cells
33%
Virulence Factors
33%
Narrative Review
33%
Parasitic Diseases
33%
Evidence-based
33%
Clinical Evidence
33%
Immune Function
33%
Parasite Proteins
33%
Lymphocyte Subsets
33%
Protein Kinase
33%
Cytokinome
33%
Parasitological
33%
Future Therapies
33%
Memory CD4+ T Cells
33%
IFN Production
33%
Expert Opinion
33%
Drug Target
33%
Area Cover
33%
Chronic Infection
33%
Cytokine Network
33%
Antiparasitic
33%
Immunological Mechanisms
33%
Parasite Virulence
33%
Significant Inflammation
33%
Appropriate Responses
33%
Tissue Cyst
33%
Recurrence Probability
33%
Clinical Correlation
33%
Ocular Trauma
33%
Medicine and Dentistry
Ocular Toxoplasmosis
100%
Immunopathogenesis
100%
Recurrent Disease
66%
Infection
33%
Aqueous Humor
33%
Toxoplasma gondii
33%
Cytokine
33%
Virulence Factor
33%
Protozoa
33%
Immune Response
33%
Protein Kinase
33%
Eye Injury
33%
Clinical Management
33%
Parasitic Disease
33%
Gamma Interferon
33%
Immune Function
33%
Antiparasitic Activity
33%
Genetic Polymorphism
33%
Lymphocyte Subpopulation
33%
Peripheral Blood Mononuclear Cell
33%
Drug Delivery System
33%
T Cell Subset
33%
Memory T Cell
33%
Parasite Virulence
33%
Primary Infection
33%
Immunology and Microbiology
Toxoplasmosis
100%
Immunopathogenesis
100%
Genetic Polymorphism
33%
Cytokine
33%
Protozoa
33%
Aqueous Humor
33%
Toxoplasma gondii
33%
Virulence Factor
33%
Peripheral Blood Mononuclear Cell
33%
Immune Response
33%
CD4
33%
Interferon Gamma
33%
Parasite Protein
33%
Lymphocyte Subpopulation
33%
Parasitic Disease
33%
Memory T Cell
33%
Parasite Virulence
33%
T Cell Subset
33%
Drug Targeting
33%
Pharmacology, Toxicology and Pharmaceutical Science
Ocular Toxoplasmosis
100%
Immunopathogenesis
100%
Recurrent Disease
66%
Inflammation
33%
Infection
33%
Cytokine
33%
Toxoplasma gondii
33%
Virulence Factor
33%
Protozoon
33%
Eye Injury
33%
Parasitosis
33%
Drug Delivery System
33%
Gamma Interferon
33%
Antiparasitic Activity
33%
Primary Infection
33%
Parasite Virulence
33%
Protein Kinase
33%